| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Interleukin-8B | 10 | 2014 | 20 | 3.040 |
Why?
|
| Receptors, Interleukin-8A | 8 | 2013 | 9 | 1.860 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 4 | 2014 | 7 | 1.420 |
Why?
|
| Prostatic Neoplasms | 5 | 2021 | 794 | 1.390 |
Why?
|
| Interleukin-8 | 7 | 2013 | 59 | 1.270 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 2 | 2019 | 3 | 1.240 |
Why?
|
| Neutrophils | 6 | 2018 | 124 | 1.140 |
Why?
|
| Arrestins | 5 | 2013 | 26 | 0.960 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2021 | 3 | 0.820 |
Why?
|
| Chemokines | 1 | 2020 | 89 | 0.720 |
Why?
|
| Signal Transduction | 11 | 2021 | 1802 | 0.640 |
Why?
|
| Cell Line, Tumor | 10 | 2021 | 2128 | 0.600 |
Why?
|
| Cytokines | 1 | 2020 | 569 | 0.580 |
Why?
|
| Mice | 18 | 2021 | 5668 | 0.540 |
Why?
|
| Chemokines, CXC | 2 | 2018 | 35 | 0.490 |
Why?
|
| Receptors, CCR5 | 2 | 2005 | 59 | 0.490 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 53 | 0.470 |
Why?
|
| Animals | 24 | 2021 | 14307 | 0.470 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2013 | 6 | 0.470 |
Why?
|
| Phosphorylation | 7 | 2014 | 878 | 0.450 |
Why?
|
| Mast Cells | 6 | 2012 | 77 | 0.450 |
Why?
|
| Neovascularization, Pathologic | 2 | 2013 | 122 | 0.410 |
Why?
|
| Chemotaxis | 2 | 2013 | 57 | 0.400 |
Why?
|
| Mice, Knockout | 8 | 2014 | 897 | 0.400 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2009 | 21 | 0.380 |
Why?
|
| Endocytosis | 2 | 2007 | 104 | 0.350 |
Why?
|
| Rats | 10 | 2013 | 3261 | 0.330 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 336 | 0.330 |
Why?
|
| Protein Kinase C | 2 | 2005 | 110 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 157 | 0.300 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2006 | 2 | 0.300 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 4 | 0.300 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2006 | 15 | 0.290 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 211 | 0.280 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 69 | 0.280 |
Why?
|
| Calcium Signaling | 4 | 2014 | 95 | 0.280 |
Why?
|
| NF-kappa B | 1 | 2008 | 306 | 0.270 |
Why?
|
| Humans | 19 | 2021 | 34853 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 1530 | 0.260 |
Why?
|
| Receptors, Steroid | 2 | 2015 | 33 | 0.250 |
Why?
|
| Disease Progression | 2 | 2019 | 580 | 0.250 |
Why?
|
| Receptors, CCR1 | 5 | 2012 | 8 | 0.250 |
Why?
|
| Receptors, IgE | 5 | 2009 | 22 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 5 | 2019 | 649 | 0.240 |
Why?
|
| Glucuronosyltransferase | 2 | 2013 | 25 | 0.230 |
Why?
|
| Cytoplasm | 1 | 2003 | 135 | 0.220 |
Why?
|
| Receptors, CXCR4 | 1 | 2003 | 67 | 0.220 |
Why?
|
| GTP-Binding Proteins | 2 | 2018 | 57 | 0.220 |
Why?
|
| Male | 8 | 2021 | 18870 | 0.220 |
Why?
|
| Cell Line | 4 | 2014 | 1289 | 0.200 |
Why?
|
| Calcium | 3 | 2014 | 445 | 0.200 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 93 | 0.200 |
Why?
|
| Peptide Fragments | 1 | 2003 | 298 | 0.200 |
Why?
|
| Receptors, Androgen | 1 | 2021 | 122 | 0.190 |
Why?
|
| Transfection | 3 | 2007 | 496 | 0.180 |
Why?
|
| Receptors, CXCR | 1 | 2018 | 6 | 0.170 |
Why?
|
| Mice, Nude | 1 | 2019 | 323 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 968 | 0.150 |
Why?
|
| Chemokines, CC | 3 | 2007 | 50 | 0.150 |
Why?
|
| HIV-1 | 1 | 2003 | 678 | 0.150 |
Why?
|
| Amino Acid Substitution | 2 | 2013 | 122 | 0.150 |
Why?
|
| Enzyme Activation | 3 | 2006 | 423 | 0.140 |
Why?
|
| Receptors, Chemokine | 3 | 2005 | 68 | 0.140 |
Why?
|
| Protein Binding | 4 | 2018 | 913 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 781 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1149 | 0.140 |
Why?
|
| Liver | 2 | 2015 | 447 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2015 | 74 | 0.130 |
Why?
|
| Wound Healing | 2 | 2013 | 69 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2014 | 7 | 0.120 |
Why?
|
| Genotype | 2 | 2013 | 641 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2014 | 360 | 0.120 |
Why?
|
| Proline | 1 | 2013 | 37 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2013 | 40 | 0.120 |
Why?
|
| Ethanol | 1 | 2015 | 188 | 0.120 |
Why?
|
| Phenylurea Compounds | 1 | 2013 | 18 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 47 | 0.110 |
Why?
|
| Glucuronides | 1 | 2012 | 10 | 0.110 |
Why?
|
| Protein Transport | 1 | 2014 | 286 | 0.110 |
Why?
|
| Leukemia, Basophilic, Acute | 1 | 2012 | 3 | 0.110 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2012 | 6 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2013 | 97 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 88 | 0.110 |
Why?
|
| Exocytosis | 1 | 2012 | 45 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 2012 | 48 | 0.110 |
Why?
|
| Vimentin | 1 | 2012 | 32 | 0.110 |
Why?
|
| Glucose | 1 | 2013 | 217 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 70 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 122 | 0.100 |
Why?
|
| Protein Structure, Secondary | 2 | 2013 | 172 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 420 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2012 | 97 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2013 | 490 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2012 | 94 | 0.100 |
Why?
|
| Conjunctiva | 2 | 2007 | 6 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2012 | 328 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 638 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 26 | 0.090 |
Why?
|
| Dimerization | 1 | 2009 | 102 | 0.090 |
Why?
|
| Psychodrama | 1 | 2009 | 4 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 75 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2009 | 140 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 91 | 0.080 |
Why?
|
| Cell Degranulation | 2 | 2005 | 10 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 78 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 120 | 0.080 |
Why?
|
| Women's Health | 1 | 2009 | 135 | 0.080 |
Why?
|
| Kinetics | 2 | 2007 | 650 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 81 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 325 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2007 | 28 | 0.080 |
Why?
|
| Cell Movement | 3 | 2005 | 545 | 0.070 |
Why?
|
| Aspartic Acid | 1 | 2007 | 46 | 0.070 |
Why?
|
| Platelet Activating Factor | 1 | 2006 | 8 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2007 | 87 | 0.070 |
Why?
|
| Pertussis Toxin | 1 | 2006 | 27 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 1124 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 1490 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2005 | 20 | 0.070 |
Why?
|
| Obesity | 1 | 2013 | 965 | 0.070 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2005 | 14 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 22 | 0.070 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2005 | 1 | 0.070 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2005 | 14 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2005 | 154 | 0.060 |
Why?
|
| Female | 6 | 2015 | 19873 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2005 | 149 | 0.060 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2003 | 1 | 0.060 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2003 | 1 | 0.060 |
Why?
|
| Dynamin I | 1 | 2003 | 3 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 1300 | 0.060 |
Why?
|
| GTP Phosphohydrolases | 1 | 2003 | 29 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2003 | 42 | 0.060 |
Why?
|
| Health Promotion | 1 | 2009 | 588 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2013 | 117 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 790 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 286 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 480 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2002 | 116 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 214 | 0.050 |
Why?
|
| Monocytes | 1 | 2003 | 258 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 100 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1426 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2012 | 1442 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2015 | 14 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2015 | 7 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2015 | 42 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 131 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 2005 | 54 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 105 | 0.030 |
Why?
|
| Glucokinase | 1 | 2013 | 3 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
|
| Hepatomegaly | 1 | 2013 | 5 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 8 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 17 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 58 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 61 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 106 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 213 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2013 | 42 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 102 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2013 | 119 | 0.030 |
Why?
|
| Species Specificity | 1 | 2013 | 233 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 608 | 0.030 |
Why?
|
| Homozygote | 1 | 2012 | 75 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 383 | 0.030 |
Why?
|
| Ligands | 1 | 2013 | 317 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2013 | 167 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 79 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2012 | 35 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 126 | 0.030 |
Why?
|
| Binding Sites | 1 | 2013 | 597 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 93 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 455 | 0.030 |
Why?
|
| Alleles | 1 | 2012 | 284 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 165 | 0.030 |
Why?
|
| Imidazoles | 1 | 2012 | 124 | 0.030 |
Why?
|
| Pyridines | 1 | 2012 | 113 | 0.030 |
Why?
|
| Aged | 2 | 2013 | 6448 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 82 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2012 | 517 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 490 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 445 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 528 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 894 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1056 | 0.020 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2009 | 53 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 9642 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 51 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 207 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 592 | 0.020 |
Why?
|
| Epithelium | 1 | 2005 | 74 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3414 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2005 | 13 | 0.020 |
Why?
|
| Chemokine CCL4 | 1 | 2005 | 18 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2005 | 12 | 0.020 |
Why?
|
| Receptors, CCR3 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 26 | 0.020 |
Why?
|
| Antigens | 1 | 2005 | 56 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2005 | 57 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2004 | 22 | 0.020 |
Why?
|
| Health Behavior | 1 | 2009 | 491 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2004 | 30 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 23 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2004 | 21 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 166 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 222 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 184 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 282 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2009 | 1961 | 0.010 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2002 | 19 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 48 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 341 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 308 | 0.010 |
Why?
|
| Inflammation | 1 | 2005 | 577 | 0.010 |
Why?
|